Geode Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-142,196
Closed -$59.8K 4576
2024
Q4
$59.8K Buy
142,196
+51,316
+56% +$42.9K ﹤0.01% 4213
2024
Q3
$179K Sell
90,880
-39,509
-30% -$150K ﹤0.01% 3940
2024
Q2
$696K Buy
130,389
+102,549
+368% +$428K ﹤0.01% 3451
2024
Q1
$83.5K Buy
27,840
+3,786
+16% +$17.7K ﹤0.01% 4217
2023
Q4
$151K Sell
24,054
-3
-0% -$23 ﹤0.01% 4040
2023
Q3
$532K Buy
24,057
+23,697
+6,583% +$618K ﹤0.01% 3582
2023
Q2
$2.54K Hold
360
﹤0.01% 4748
2023
Q1
$16.6K Sell
360
-6
-2% -$655 ﹤0.01% 4725
2022
Q4
$52K Buy
366
+58
+19% +$11.9K ﹤0.01% 4581
2022
Q3
$173K Hold
308
﹤0.01% 4295
2022
Q2
$248K Sell
308
-8
-3% -$11.9K ﹤0.01% 4138
2022
Q1
$828K Buy
316
+13
+4% +$27.6K ﹤0.01% 3701
2021
Q4
$782K Hold
303
﹤0.01% 3831
2021
Q3
$1.39M Buy
303
+4
+1% +$20.1K ﹤0.01% 3520
2021
Q2
$1.78M Buy
299
+39
+15% +$252K ﹤0.01% 3317
2021
Q1
$2.1M Buy
260
+68
+35% +$720K ﹤0.01% 3232
2020
Q4
$1.19M Sell
192
-3
-2% -$18.4K ﹤0.01% 3315
2020
Q3
$1.32M Buy
195
+53
+37% +$393K ﹤0.01% 3099
2020
Q2
$899K Sell
142
-10
-7% -$42.5K ﹤0.01% 3173
2020
Q1
$493K Buy
152
+76
+100% +$316K ﹤0.01% 3277
2019
Q4
$443K Buy
76
+1
+1% +$9.45K ﹤0.01% 3542
2019
Q3
$941K Sell
75
-1
-1% -$8.03K ﹤0.01% 3257
2019
Q2
$634K Sell
76
-12
-14% -$141K ﹤0.01% 3382
2019
Q1
$1.16M Buy
88
+13
+17% +$221K ﹤0.01% 3103
2018
Q4
$1.13M Buy
75
+3
+4% +$70.5K ﹤0.01% 3055
2018
Q3
$2.7M Buy
72
+6
+9% +$198K ﹤0.01% 2722
2018
Q2
$2.57M Buy
66
+39
+144% +$1.48M ﹤0.01% 2711
2018
Q1
$872K Hold
27
﹤0.01% 3188
2017
Q4
$554K Buy
27
+8
+42% +$165K ﹤0.01% 3318
2017
Q3
$397K Hold
19
﹤0.01% 3439
2017
Q2
$304K Sell
19
-5
-21% -$100K ﹤0.01% 3537
2017
Q1
$643K Buy
24
+1
+4% +$28.1K ﹤0.01% 3215
2016
Q4
$616K Buy
23
+1
+5% +$30.8K ﹤0.01% 3196
2016
Q3
$809K Hold
22
﹤0.01% 3059
2016
Q2
$858K Buy
22
+2
+10% +$90.3K ﹤0.01% 2980
2016
Q1
$987 Hold
20
﹤0.01% 2886
2015
Q4
$1.07M Buy
20
+12
+150% +$647K ﹤0.01% 2881
2015
Q3
$349K Hold
8
﹤0.01% 3403
2015
Q2
$613K Buy
8
+1
+14% +$86.8K ﹤0.01% 3114
2015
Q1
$543K Buy
7
+1
+17% +$92.8K ﹤0.01% 3163
2014
Q4
$536K Buy
6
+1
+20% +$82.4K ﹤0.01% 3158
2014
Q3
$488K Buy
+5
New +$465K ﹤0.01% 3184

Geode Capital Management's TTOO Position: Q1 2025 in Review

Geode Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 142,196 shares — an estimated $59.8K sold.

Geode Capital Management first reported a position in TTOO in Q3 2014 and held it in 42 quarters. The position peaked at $2.7M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.

  • Geode Capital Management reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
  • Geode Capital Management sold 142,196 T2 Biosystems, Inc shares in Q1 2025, an estimated $59.8K.
  • Geode Capital Management first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 42 quarters.
  • Geode Capital Management's T2 Biosystems, Inc position peaked at $2.7M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.